Phase Forward Relocates Corporate Headquarters; Expanded Facilities to Accommodate Growth.

Business Editors

WALTHAM, Mass.--(BUSINESS WIRE)--Dec. 15, 2003

Phase Forward, the leading provider of data management solutions for clinical trials and drug safety, today announced the relocation of its corporate headquarters. Necessitated by corporate growth, the new 100,000 square foot office provides Phase Forward with approximately 60 percent more space than its existing location. The company's new headquarters, located at the Waltham Woods Corporate Center at 880 Winter Street in Waltham, represent one of the largest corporate headquarter relocations in greater Boston this year. Waltham Woods Corporate Center was the recipient of the Building of the Year Award for 2003 by the Building Owners and Managers Association of New England.

"Our new headquarters will allow us to grow our employee base and infrastructure in order to support Phase Forward's expansion," said Bob Weiler, president and chief executive officer of Phase Forward. "In addition, the new layout will contribute to increased productivity by fostering collaboration among employees."

In the five years since Phase Forward introduced its web-based EDC solution, the company has grown organically and through acquisition to become the world leader in integrated clinical data management and safety solutions. Phase Forward's InForm(TM) solution for electronic data capture (EDC) has been used in more than 400 trials throughout 85 countries by 12,000 clinical sites. Additionally, the Clintrial(TM) clinical data management solution (CDMS) has been used to manage more than 4,500 trials, establishing Phase Forward as the market leader in both EDC and CDMS worldwide. Clintrace(TM), Phase Forward's adverse event tracking and reporting system, has managed tens of thousands of adverse events across the globe.

Phase Forward will open the doors to its new headquarters in mid-December. The new address is: Phase Forward, Inc., 880 Winter Street, Waltham, Massachusetts 02451.

About Phase Forward

Phase Forward is the leading provider of integrated data management solutions for clinical trials and drug safety. The company is dedicated to helping pharmaceutical, biotechnology, and medical device companies bring needed drugs and therapies to market faster and more safely. Phase Forward offers proven solutions in electronic data capture (EDC), clinical data management (CDM), and adverse event reporting (AER). Phase Forward products and services are used by 11 of the top 15 pharmaceutical companies and more than 300 organizations worldwide including: Aventis, Baxter International, Biogen, Boston Scientific, Cedars-Sinai, Eli Lilly and Company, GlaxoSmithKline, Guidant, Medtronic, Procter & Gamble, Quintiles, Schering-Plough, and Serono. Phase Forward is headquartered in Waltham, Massachusetts with offices in the United Kingdom, Australia, France, and Japan. Additional information about Phase Forward is available at www.phaseforward.com.